Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Aging (Upcoming)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • Gut-Brain Axis (Jul 2021)
    • Tumor Microenvironment (Mar 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI117215

Anti-tumor necrosis factor modulates anti-CD3-triggered T cell cytokine gene expression in vivo.

C Ferran, F Dautry, S Mérite, K Sheehan, R Schreiber, G Grau, J F Bach, and L Chatenoud

Institut National de la Sante et de la Recherche Medicale, U-25, Hôpital Necker, Paris, France.

Find articles by Ferran, C. in: JCI | PubMed | Google Scholar

Institut National de la Sante et de la Recherche Medicale, U-25, Hôpital Necker, Paris, France.

Find articles by Dautry, F. in: JCI | PubMed | Google Scholar

Institut National de la Sante et de la Recherche Medicale, U-25, Hôpital Necker, Paris, France.

Find articles by Mérite, S. in: JCI | PubMed | Google Scholar

Institut National de la Sante et de la Recherche Medicale, U-25, Hôpital Necker, Paris, France.

Find articles by Sheehan, K. in: JCI | PubMed | Google Scholar

Institut National de la Sante et de la Recherche Medicale, U-25, Hôpital Necker, Paris, France.

Find articles by Schreiber, R. in: JCI | PubMed | Google Scholar

Institut National de la Sante et de la Recherche Medicale, U-25, Hôpital Necker, Paris, France.

Find articles by Grau, G. in: JCI | PubMed | Google Scholar

Institut National de la Sante et de la Recherche Medicale, U-25, Hôpital Necker, Paris, France.

Find articles by Bach, J. in: JCI | PubMed | Google Scholar

Institut National de la Sante et de la Recherche Medicale, U-25, Hôpital Necker, Paris, France.

Find articles by Chatenoud, L. in: JCI | PubMed | Google Scholar

Published May 1, 1994 - More info

Published in Volume 93, Issue 5 on May 1, 1994
J Clin Invest. 1994;93(5):2189–2196. https://doi.org/10.1172/JCI117215.
© 1994 The American Society for Clinical Investigation
Published May 1, 1994 - Version history
View PDF
Abstract

De novo expression of TNF, IFN gamma, IL-3, IL-4, and IL-6 genes was initiated rapidly by treatment of mice with anti-CD3. A specific feature of this reaction was that TNF was derived exclusively from T cells. TNF was produced both as a mature soluble trimeric protein and as a 26-kD anti-TNF-reactive protein compatible with membrane-anchored TNF. Pretreatment with anti-TNF did not affect anti-CD3-triggered TNF mRNA expression in T cells. In contrast, in vivo and in vitro anti-TNF treatment upregulated anti-CD3-induced IFN gamma mRNA expression and inhibited IL-4 mRNA expression. These latter effects were not dependent on TNF neutralization: pretreatment with soluble recombinant 55-kD TNF receptor (TBPI) as an alternative TNF-neutralizing agent did not modify the anti-CD3-induced cytokine profile. These results suggest that a direct interaction between anti-TNF and T cell membrane-anchored TNF could account for the observed modulation of cytokine gene expression. The increased expression of INF gamma mRNA observed in anti-TNF-treated animals correlated with a decrease in IL-3 and IL-6 mRNA expression. Conversely, IFN gamma blockade by a neutralizing anti-IFN gamma mAb led to a substantial increase in both IL-3 and IL-6 gene expression induced by anti-CD3. Taken together, these results strongly argue for the existence, in the anti-CD3-induced cytokine cascade, of IFN gamma-dependent regulation of IL-3 production, which in turn modulates IL-6 production.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 2189
page 2189
icon of scanned page 2190
page 2190
icon of scanned page 2191
page 2191
icon of scanned page 2192
page 2192
icon of scanned page 2193
page 2193
icon of scanned page 2194
page 2194
icon of scanned page 2195
page 2195
icon of scanned page 2196
page 2196
Version history
  • Version 1 (May 1, 1994): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2022 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts